UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 5 Issue 11
November-2018
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1811282


Registration ID:
191416

Page Number

625-634

Share This Article


Jetir RMS

Title

Upholding the Polyribosyl ribitol phosphate (PRP) content in different stages in manufacturing of Haemophilus influenzae type b (Hib) conjugate vaccine

Abstract

Haemophilus influenzae type b (Hib) causes many severe diseases, including epiglottitis, pneumonia, sepsis, and meningitis (David W McCormick and Elizabeth M Molyneux, 2011). In developed countries, the annual incidence of meningitis caused by bacteria is approximately 5–10 cases per population of 100,000. The Hib conjugate vaccine is considered protective, safe and Effective control (Verma R et al., 2011). Many factors may play a role in the immunogenicity of Hib conjugate vaccines, such as the polysaccharides and proteins carrier used in vaccine construction, as well as the method of conjugation (Heikki Peltola, 2000). A Hib conjugate vaccine has been constructed via chemical synthesis of a Hib saccharide antigen. Two models of carbohydrate-protein conjugate have been established, the single ended model (terminal amination-single method) and cross-linked lattice matrix (dual amination method). HPAEC-PAD (high performance anion-exchange chromatography with pulsed amperometric detection) method was used for free polysaccharide estimation using PRP standard obtained from NIBSC. Maintain the PRP content in different stages are more vital for the effective production of Hib conjugate vaccine.

Key Words

Haemophilus type b conjugate, Polyribosyl ribitol phosphate (PRP), immunogenicity.

Cite This Article

"Upholding the Polyribosyl ribitol phosphate (PRP) content in different stages in manufacturing of Haemophilus influenzae type b (Hib) conjugate vaccine", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.5, Issue 11, page no.625-634, November-2018, Available :http://www.jetir.org/papers/JETIR1811282.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Upholding the Polyribosyl ribitol phosphate (PRP) content in different stages in manufacturing of Haemophilus influenzae type b (Hib) conjugate vaccine", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 11, page no. pp625-634, November-2018, Available at : http://www.jetir.org/papers/JETIR1811282.pdf

Publication Details

Published Paper ID: JETIR1811282
Registration ID: 191416
Published In: Volume 5 | Issue 11 | Year November-2018
DOI (Digital Object Identifier):
Page No: 625-634
Country: Secundrabad, Telangana, India .
Area: Biological Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002862

Print This Page

Current Call For Paper

Jetir RMS